Paper - WANFANG MED ONLINE

Contact US | Chinese

You Position: Home > Paper

Guideline for diagnosis and treatment of liver failure

( views:228, downloads:604 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 6

DOI:: 10.3760／cma.j.issn.1674-2397.2018.06.001

Key Word:: 肝功能衰竭;肝,人工;诊断;治疗;指南;Liver failure;Artificial liver;Diagnosis;Treatment;Guideline

Abstract： No abstract available

Reference

[1]中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝治疗肝衰竭指南（2016年版）[J].2016,(2).
[2]中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南（2012年版）[J].2012,(6).
[3]中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].2006,(9).
[4]饶慧瑛,郭芳,魏来.2005年美国肝病学会急性肝衰竭诊治和肝移植患者评价指南简介[J].2006,(2).
[5]中华医学会肝病学分会.肝硬化肝性脑病诊疗指南[J].2018,(10).
[6]Saliba,F.,Camus,C.,Durand,F.,etc.Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: A randomized, controlled trial[J].2013,159(8).
[7]Jody A, Rule,Linda S, Hynan,Nahid, Attar,etc.Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver Failure.[J].2015,10.
[8]Jindal,A.,Kumar,M.,Sarin,S.K..Management of acute hepatitis B and reactivation of hepatitis B[J].2013,33(Suppl.1).
[9]C N, Broussard,A, Aggarwal,S R, Lacey,etc.Mushroom poisoning--from diarrhea to liver transplantation.[J].2001,96(11).
[10]Karvellas, Constantine J.,Cavazos, Jorge,Battenhouse, Holly,etc.Effects of Antimicrobial Prophylaxis and Blood Stream Infections in Patients With Acute Liver Failure: A Retrospective Cohort Study[J].2014,12(11).
[11]European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu,European Association for the Study of the Liver.EASL Clinical Practice Guidelines on nutrition in chronic liver disease.[J].2018.
[12]Joana Pedro da Silva, Silvestre,Luis Miguel da Cruz, Coelho,Pedro Manuel Sarmento Rodrigues, Póvoa.Impact of fulminant hepatic failure in C-reactive protein?[J].2010,25(4).
[13].EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure[J].2017,66(5).
[14]Mindikoglu, A. L.,Pappas, S. C..New developments in hepatorenal syndrome (vol 16, pg 162, 2018)[J].2018,16(6).
[15]Shiv Kumar Sarin,Chan Kumar Kedarisetty,Zaigham Abbas,etc.Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J].2014,8(4).
[16]Lee WM,Hynan LS,Rossaro L,etc.Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.[J].2009,137(3).
[17]R, Jalan,S W, Olde Damink,N E, Deutz,etc.Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia.[J].2001,34(1).
[18]Lu-Lu, Lin,Shi-Ming, Du,Yan, Fu,etc.Combination therapy versus pharmacotherapy, endoscopic variceal ligation, or the transjugular intrahepatic portosystemic shunt alone in the secondary prevention of esophageal variceal bleeding: a meta-analysis of randomized controlled trials.[J].2017,(Spec ).
[19]Satoshi, Mochida.Indication criteria for liver transplantation for acute liver failure in Japan.[J].2008,38 Suppl 1.
[20]Klinck, J.,McNeill, L.,Di Angelantonio, E.,etc.Predictors and outcome impact of perioperative serum sodium changes in a high-risk population[J].2015,114(4).
[21]Long, Yan,Feng, Xie,Jiongjiong, Lu,etc.The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.[J].2015,15.
[22]Vilstrup,H.,Amodio,P.,Bajaj,J.,etc.Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver[J].2014,60(2).
[23]M J, Smilkstein,G L, Knapp,K W, Kulig,etc.Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)[J].1988,319(24).
[24]T F, Imperiale,J C, Teran,A J, McCullough.A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage.[J].1995,109(4).
[25]European Association for the Study of the Liver.EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J].2018,69(2).
[26]Petrof,E.O.,Khoruts,A..From stool transplants to next-generation microbiota therapeutics[J].2014,146(6).
[27]Tofteng F,Larsen FS.The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure.[J].2004,24(7).
[28]Leontiadis GI,Howden CW,Sharma VK.Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials.[J].2007,82(3).
[29]Qi Ling,Xiao Xu,Qiang Wei,etc.Downgrading MELD Improves the Outcomes after Liver Transplantation in Patients with Acute-on-Chronic Hepatitis B Liver Failure.[J].2012,7(1).
[30]Scalea, Thomas M.,Stein, Deborah M.,Hanish, Steven I.,etc.Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure[J].2017,266(4).
[31]Yang F,Li L,Lu H,etc.Characterization of fecal microbial communities in patients with liver cirrhosis.[J].2011,54(2).
[32]European Association for the Study of the Liver.EASL Recommendations on Treatment of Hepatitis C 2018[J].2018,69(2).
[33]L, Laine,D, Cook.Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.[J].1995,123.
[34]Tilg, Herbert,Cani, Patrice D.,Mayer, Emeran A..Gut microbiome and liver diseases[J].2016,65(12).
[35]Flamm, Steven L.,Yang, Yu-Xiao,Singh, Siddharth,etc.American Gastroenterological Association Institute Guidelines for the Diagnosis and Management of Acute Liver Failure[J].2017,152(3).
[36]N M, Selby,A K, Kubba,C J, Hawkey.Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'.[J].2000,14(9).
[37]Vicente, Arroyo,Richard, Moreau,Patrick S, Kamath,etc.Acute-on-chronic liver failure in cirrhosis.[J].2016.
[38]M, Laccetti,G, Manes,G, Uomo,etc.Flumazenil in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double blind randomized placebo controlled study.[J].2000,32(4).
[39]Wendon J,Pereira SP,Fitt S,etc.Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K(1)) in severe acute liver disease.[J].2005,42(3).
[40]G, Ioannou,J, Doust,D C, Rockey.Terlipressin for acute esophageal variceal hemorrhage.[J].2003,(1).
[41]Michael, Linecker,Tanja, Krones,Thomas, Berg,etc.Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.[J].2017,(Spec ).
[42]R, Keays,P M, Harrison,J A, Wendon,etc.Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.[J].1991,303(6809).
[43]Amouroux N,Nouguier Soule J,Guillon S,etc.Treatment of amatoxin poisoning: 20-year retrospective analysis.[J].2002,40(6).
[44]Qian, Zhang,Ying, Li,Tao, Han,etc.Comparison of current diagnostic criteria for acute-on-chronic liver failure.[J].2015,10(3).
[45]Haruki Uojima,Takeshi Kinbara,Hisashi Hidaka,etc.Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites[J].2017,47(3).
[46]Lise Lotte, Gluud,Gitte, Dam,I?igo, Les,etc.Branched-chain amino acids for people with hepatic encephalopathy.[J].2015,9.
[47]Auzinger G,Wendon J,Dhawan A,etc.Acute liver failure.[J].2010,376(9736).
[48]K, Hruby,G, Csomos,M, Fuhrmann,etc.Chemotherapy of Amanita phalloides poisoning with intravenous silibinin.[J].1983,2(2).
[49]Farmakiotis, D.,Kontoyiannis, D. P..Emerging Issues With Diagnosis and Management of Fungal Infections in Solid Organ Transplant Recipients[J].2015,15(5).
[50]Jalan,R.,Yurdaydin,C.,Bajaj,J.S.,etc.Toward an improved definition of acute-on-chronic liver failure[J].2014,147(1).
[51]Kramer DJ,Van Rensburg A,Steadman RH.Transplantation for acute liver failure: perioperative management.[J].2010,15(3).
[52]Gluud, Lise L.,Vilstrup, Hendrik,Morgan, Marsha Y..Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis[J].2016,64(3).
[53].L-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials[J].2013,28(5).
[54]Rockey DC,Seeff LB,Rochon J,etc.Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.[J].2010,51(6).
[55]Philpott Howard J,Williams R,Rolando N.Bacterial and fungal infection in acute liver failure.[J].1996,16(4).
[56]William M. Lee,Julie Poison.AASLD Position Paper: The Management of Acute Liver Failure[J].2005,41(5).
[57]J Canalese,A E Gimson,C Davis,etc.Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.[J].1982,23(7).
[58]Lee A,Hayes PC,Damink SW,etc.Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure.[J].1999,354(9185).

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn